Security key
75382E109
RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RAPT)
CUSIP: 75382E109
Q4 2020 13F Holders as of 31 Dec 2020
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 20,445,788
- Total 13F value
- $403,803,000
- Share change
- +767,901
- Put/Call ratio
- 121%
- SEC-reported price per share
- $19.75
- Number of holders
- 80
- Value change
- +$1,193,976
- Number of buys
- 48
- Number of sells
- 33
- Shares outstanding
- 27,725,634
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2020
Institutions
80
Top holders
10
RAPT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
RAPT Therapeutics, Inc. SEC filings
RAPT Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75382E109
Recent filing periods:
Ownership snapshot
Top reported holders of RAPT - RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Peter Svennilson
Disclosed value leader
Peter Svennilson
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F
Lead comparable stake: 20%
Showing 1-6 of 15 holder rows.
Quick read
Peter Svennilson leads the comparable SEC ownership view at 20%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Peter Svennilson's linked filing trail.
Comparable ownership
Top 5
Peter Svennilson
20%
PRICE T ROWE ASSOCIATES INC /MD/
9.5%
WELLINGTON MANAGEMENT GROUP LLP
5.8%
Of The University Of California R...
5%
BlackRock Finance, Inc.
4.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Peter Svennilson |
13F
Individual
|
20%
|
$181,302,000
5,630,497 shares
|
— | 30 Sep 2020 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
9.5%
|
$84,622,000
2,628,020 shares
|
— | 30 Sep 2020 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
5.8%
|
$51,412,000
1,596,657 shares
|
— | 30 Sep 2020 |
| Of The University Of California Regents |
13F
Individual
|
5%
|
$44,459,000
1,380,704 shares
|
— | 30 Sep 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
4.3%
|
$38,300,000
1,189,443 shares
|
— | 30 Sep 2020 |
| Alphabet Inc. |
13F
Company
|
3%
|
$26,921,000
836,059 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
80
Shares
20,445,788
Rows available
80
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2020 vs Q4 2025 Across Filers
Q4 2025 holders
3
Q4 2020 holders
80
Holder diff
77
| Investor | Q4 2025 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend